These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10231533)

  • 1. Characterization of 2-oxo-3-pentynoate as an active-site-directed inactivator of flavoprotein oxidases: identification of active-site peptides in tryptophan 2-monooxygenase.
    Gadda G; Dangott LJ; Johnson WH; Whitman CP; Fitzpatrick PF
    Biochemistry; 1999 May; 38(18):5822-8. PubMed ID: 10231533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of 4-oxalocrotonate tautomerase by 2-oxo-3-pentynoate.
    Johnson WH; Czerwinski RM; Fitzgerald MC; Whitman CP
    Biochemistry; 1997 Dec; 36(50):15724-32. PubMed ID: 9398301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the roles of amino acid residues in the flavoprotein tryptophan 2-monooxygenase modified by 2-oxo-3-pentynoate: characterization of His338, Cys339, and Cys511 mutant enzymes.
    Sobrado P; Fitzpatrick PF
    Arch Biochem Biophys; 2002 Jun; 402(1):24-30. PubMed ID: 12051679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an essential tyrosine residue in nitroalkane oxidase by modification with tetranitromethane.
    Gadda G; Banerjee A; Fitzpatrick PF
    Biochemistry; 2000 Feb; 39(5):1162-8. PubMed ID: 10653664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a cysteine residue in the active site of nitroalkane oxidase by modification with N-ethylmaleimide.
    Gadda G; Banerjee A; Dangott LJ; Fitzpatrick PF
    J Biol Chem; 2000 Oct; 275(41):31891-5. PubMed ID: 10913134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis.
    Taylor AB; Czerwinski RM; Johnson WH; Whitman CP; Hackert ML
    Biochemistry; 1998 Oct; 37(42):14692-700. PubMed ID: 9778344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a newly identified mycobacterial tautomerase with promiscuous dehalogenase and hydratase activities reveals a functional link to a recently diverged cis-3-chloroacrylic acid dehalogenase.
    Baas BJ; Zandvoort E; Wasiel AA; Quax WJ; Poelarends GJ
    Biochemistry; 2011 Apr; 50(14):2889-99. PubMed ID: 21370851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Tyr413 as an active site residue in the flavoprotein tryptophan 2-monooxygenase and analysis of its contribution to catalysis.
    Sobrado P; Fitzpatrick PF
    Biochemistry; 2003 Dec; 42(47):13833-8. PubMed ID: 14636050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of the flavoprotein tryptophan 2-monooxygenase expressed at high levels in Escherichia coli.
    Emanuele JJ; Heasley CJ; Fitzpatrick PF
    Arch Biochem Biophys; 1995 Jan; 316(1):241-8. PubMed ID: 7840624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent modification and site-directed mutagenesis of an active site tryptophan of human prostatic acid phosphatase.
    Zhang Z; Ostanin K; Van Etten RL
    Acta Biochim Pol; 1997; 44(4):659-72. PubMed ID: 9584846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of covalently inhibited extracellular lipase from Streptomyces rimosus by matrix-assisted laser desorption/ionization time-of-flight and matrix-assisted laser desorption/ionization quadrupole ion trap reflectron time-of-flight mass spectrometry: localization of the active site serine.
    Zehl M; Lescić I; Abramić M; Rizzi A; Kojić-Prodić B; Allmaier G
    J Mass Spectrom; 2004 Dec; 39(12):1474-83. PubMed ID: 15578758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
    He K; Falick AM; Chen B; Nilsson F; Correia MA
    Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an essential arginine in the flavoprotein nitroalkane oxidase.
    Gadda G; Banerjee A; Fleming GS; Fitzpatrick PF
    J Enzyme Inhib; 2001; 16(2):157-63. PubMed ID: 11342284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
    Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
    Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, expression, and characterization of a cis-3-chloroacrylic acid dehalogenase: insights into the mechanistic, structural, and evolutionary relationship between isomer-specific 3-chloroacrylic acid dehalogenases.
    Poelarends GJ; Serrano H; Person MD; Johnson WH; Murzin AG; Whitman CP
    Biochemistry; 2004 Jan; 43(3):759-72. PubMed ID: 14730981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific alkylation of cis-3-chloroacrylic acid dehalogenase by (R)-oxirane-2-carboxylate: analysis and mechanistic implications.
    Poelarends GJ; Serrano H; Johnson WH; Whitman CP
    Biochemistry; 2004 Jun; 43(22):7187-96. PubMed ID: 15170356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modification of lysyl residues of Rhodotorula gracilis D-amino acid oxidase.
    Gadda G; Beretta GL; Pilone MS
    Biochem Mol Biol Int; 1994 Aug; 33(5):947-55. PubMed ID: 7987263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited proteolysis and X-ray crystallography reveal the origin of substrate specificity and of the rate-limiting product release during oxidation of D-amino acids catalyzed by mammalian D-amino acid oxidase.
    Vanoni MA; Cosma A; Mazzeo D; Mattevi A; Todone F; Curti B
    Biochemistry; 1997 May; 36(19):5624-32. PubMed ID: 9153402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of site-directed irreversible folate analogue inhibitors of thymidylate synthase.
    Lobo AP; Nair MG; Changchien L; Weichsel A; Montfort WR; Maley F
    Biochemistry; 1998 Mar; 37(13):4535-42. PubMed ID: 9521774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.